PEDIATRICS Vol. 58 No. 5 November 1976, pp. 740-743
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shapiro, G. G.
Right arrow Articles by Bierman, C. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shapiro, G. G.
Right arrow Articles by Bierman, C. W.

The Paradoxical Effect of Adrenergic and Methylxanthine Drugs in Cystic Fibrosis

Gail G. Shapiro M.D.1, Jacquelyn Bamman M.D.1, Paula Kanarek D.Sc.1, and C. Warren Bierman M.D.1

1 Department of Pediatrics, University of Washington School of Medicine, Seattle

This study examined the effect of aerosolized isoproterenol and oral theophylline on pulmonary function in cystic fibrosis (CF) to determine how often these drugs are beneficial and whether there is a correlation between response to isoproterenol and response to oral theophylline.

After obtaining baseline pulmonary function tests before and after isoproterenol aerosol, 12 patients with CF were put on a double-blind trial of high-dosage theophylline (10 mg/kg three times per day) or placebo for four weeks and were then switched to the alternate regimen for the next four weeks. Patients had weekly evaluations of pulmonary function and plasma theophylline determinations.

Gastrointestinal side effects were common with theophylline. The responses to aerosolized bronchodilators were inconsistent from week to week. After aerosolized bronchodilator, five of 12 patients had an average increase of 10% or more in FEF45%-55% and FEFT70%-80%. While taking oral theophylline, five patients had a 10% or more decrease in FEF45%-55% and six patients had a decrease in FEF70%-80%.

We conclude that there was no concorrdance between response to isoproterenol and theophylline, and that adrenergic and methylxanthine drugs must be used with caution in patients with CF.

Submitted on November 25, 1975
Accepted on February 26, 1976




This article has been cited by other articles:


Home page
 Journal of Pharmacy PracticeHome page
J. H. Tran and K. M. Brennan
Management of the Child With Cystic Fibrosis
Journal of Pharmacy Practice, February 1, 1996; 9(1): 75 - 90.
[Abstract] [PDF]